New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA
New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA JEDDAH, July 30, 2025 – Jamjoom Pharma, a leading Saudi pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products across MEA, and Althera Laboratories, a company dedicated to developing and commercializing…